Loading company…
Taihao Biotech develops and produces microfluidic molecular diagnostic point-of-care testing systems.
Founded in 2021, Taihao Biotech develops, designs, and produces microfluidic molecular diagnostic point-of-care testing systems. It also provides microfluidic technology combining biotechnology, micro and nano manufacturing, and optoelectronics. The company is based in Beijing, China, and closed venture funding from Shanda Capital in November 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in